Lynn C. Tyler is a partner and registered patent lawyer in the firm’s Intellectual Property Department. Mr. Tyler helps innovative companies secure and preserve their market position and competitive advantage by navigating their way through the FDA to the marketplace and enforcing their intellectual property rights, which often must be protected against imitators who seek to reap where they have not sown. He litigates intellectual property matters and represents clients at all stages of the process, including pre-litigation counseling, alternative dispute resolution, formal and informal discovery, trial, and appeal.
Mr. Tyler also chairs the firm’s Food, Drug and Device Law Practice Group. He counsels food industry clients on matters such as advertising and promotion, FDA inspections, imports, labeling, registration, reporting and packaging, and medical device companies on matters such as inspections, 510(k)s, and labeling and promotion issues. Mr. Tyler authored a chapter titled, "The FDA's Regulation of Off-Label Promotion: Has the Supreme Court's Decision in Sorrell v. IMS Health Cracked the Foundation?" in the book, Inside the Minds: Recent Developments in Food and Drug Law (2013 ed). In the fall of 2012, he taught a course on FDA law at the Indiana University Maurer School of Law in Bloomington.
Mr. Tyler has represented clients in federal courts throughout the country in cases involving patents, trademarks and trade dress, trade secrets, antitrust, non-compete agreements, and unfair competition. Mr. Tyler has also represented clients in Section 337 investigations before the International Trade Commission. Some of the technologies involved in these cases include artificial hips, automotive fuel caps, ballistics software, blood glucose monitors and other blood assays and analyzers, cable television test equipment, cement kilns, e-commerce software, pharmaceuticals, and spinal implants. He has participated in more than 15 trials and injunction hearings in complex commercial matters. For appellate matters, he has been the lead counsel in over 30 cases before the Supreme Court of the United States and various federal and state courts. He is admitted to practice before the Supreme Court of the United States, several federal Courts of Appeals, and the Supreme Court of Indiana.
Mr. Tyler is listed in The Best Lawyers in America in multiple categories in addition to his listings in Indiana Super Lawyers and an AV Preeminent rating in Intellectual Property Law by Martindale-Hubbell. In 2014, 2016 and 2017, he was recognized by Best Lawyers as Indianapolis Patent Litigator of the Year. He is the author of numerous articles on issues of intellectual property, FDA law, or federal procedure published in a variety of peer-reviewed publications. In 2010, one of his articles won the prestigious Burton Award for Legal Achievement.
Mr. Tyler is the vice chair of AIPLA's Food and Drug Committee and is the co-chair of the Biosimilars Subcommittee for the AIPLA's Biotech Committee, and a member of the FDLI's Medical Device Committee. He is a member of the 7th Circuit, Federal Circuit, and Indiana State Bar Associations.
His civic activities include being a co-founder, past president, and volunteer for the Neighborhood Christian Legal Clinic (NCLC) and past chairman of the Indianapolis Civic Theatre (1999-2002). For his work on behalf of the NCLC, he received the Indianapolis Bar Association's Pro Bono Award in 2002 and was a co-recipient of the firm's inaugural Joseph A. Maley Pro Bono Award in 2009. Currently, he serves on the board and is the Secretary of the Indiana Chapter of the Juvenile Diabetes Research Foundation.
Mr. Tyler graduated summa cum laude in 1981 from the University of Notre Dame and received his J.D., magna cum laude, from the University of Michigan Law School in 1984. He was a member of the Michigan Law Review and elected to the Order of Coif. He also received a M.S. in Biology from IUPUI in 2007.